Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

Euro Heart Index 2016: France ranks 1st in heart care

Euro Heart Index 2016: France ranks 1st in heart care

New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

NCDR provides data to study appropriate use of oral anticoagulant therapy

NCDR provides data to study appropriate use of oral anticoagulant therapy

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

New study to examine genomics of anti-platelet therapy after coronary interventions

New study to examine genomics of anti-platelet therapy after coronary interventions

'Novel' analysis addresses antiplatelet benefits in real-world CHD patients

'Novel' analysis addresses antiplatelet benefits in real-world CHD patients

CYP2C19 gene variants undermine clopidogrel stroke prevention

CYP2C19 gene variants undermine clopidogrel stroke prevention

Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Younger women more likely to experience one-year adverse cardiovascular events after PCI

Younger women more likely to experience one-year adverse cardiovascular events after PCI

UPMC uses simple gene test to personalize medications for patients undergoing heart catheterization

UPMC uses simple gene test to personalize medications for patients undergoing heart catheterization

New study finds efficacy of novel intravenous blood thinner in women

New study finds efficacy of novel intravenous blood thinner in women

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

Administering ticagrelor in the ambulance cuts ischaemic events 24 hours following PCI

Administering ticagrelor in the ambulance cuts ischaemic events 24 hours following PCI

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

DAPT Study shows dual antiplatelet therapy reduces bleeding-related mortality

DAPT Study shows dual antiplatelet therapy reduces bleeding-related mortality

Prasugrel linked to high-bleeding-risk in patients with stable coronary artery disease

Prasugrel linked to high-bleeding-risk in patients with stable coronary artery disease

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

ESC Congress to highlight results from global trials in six press conferences

ESC Congress to highlight results from global trials in six press conferences